TOP HEADLINES

Featured Story

Cook Medical recalling 17,000+ catheters and pressure monitoring sets due to tip separation

Cook Medical is recalling 17,827 single-lumen central venous catheters and pressure monitoring sets and trays because of concerns about catheter tip fracture and/or separation. The FDA posted the Bloomington, IN's company's recall on its website, an action it takes from time to time to publicize recalls that are critical to patient safety.

SI-Bone's spinal fusion implant gains near-total Medicare coverage on back of strong studies

SI-Bone's iFuse Implant System is one state away from nationwide Medicare coverage. Medicare Administrative Contractor National Government Services has agreed to reimburse the spinal implant used to treat sacroiliac joint disruption and degenerative sacroiliitis via minimally invasive spinal fusion.

Indian genomics lab MedGenome puts $10M toward 100K genome project in South Asia

An alliance of for-profit companies and academia is supporting the GenomeAsia 100K project that seeks to do whole-genome sequencing on 100,000 people in South Asia. Now, startup MedGenome has said it will kick in $10 million toward the effort to become a founding member.

GV charts its own course with big bets on med tech: Bloomberg

VC firms traditionally take a measured approach to med tech investing, but GV, formerly Google Ventures, is bucking the trend. The company is betting big on companies with innovative technologies despite potential regulatory obstacles.

Pfizer teams with Silicon Valley incubator to promote consumer health startups

Pfizer Consumer Healthcare announced the launch of joint health and wellness innovation program that will enable 10 med tech startups to utilize the San Francisco office of tech industry incubator Galvanize.

MORE NEWS

From Our Sister Sites

FiercePharmaAsia

Mumbai-based Sun Pharmaceutical Industries wants the U.S. FDA to re-inspect its troubled Halol plant between April and June after efforts at answering complaints from a leaky ceiling that were first noted in September 2014 and some of which were highlighted in a December 2015 warning letter as still pending.  

FiercePharma

India's Sun Pharmaceutical saw its sales in the U.S., its largest market, continue to fall as problems with a key plant in India have yet to be resolved. U.S. sales were off 11% to $486 million in the quarter ended Dec. 31, 2015, India's largest drugmaker reported today.